Skin testing for inhalant allergy 2003: Current strategies

Otolaryngology - Head and Neck Surgery

Volumn 129, Issue SUPPL. 4, 2003, Pages

  Krouse, John H ^a   Mabry, Richard L ^a  

^a 5E UHC ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ALLERGY; ALTERNARIA; CAT; COCKROACH; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DIAGNOSTIC VALUE; GRASS; HUMAN; HYPHOMYCETES; INTRACUTANEOUS TEST; OAK; PENICILLIUM; PRACTICE GUIDELINE; PRICK TEST; RAGWEED; REVIEW; SKIN TEST;

EID: 0141889123     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)01398-6     Document Type: Article

References (44)

1. Wyman M. Autumnal catarrh. Cambridge: Hurd & Houghton; 1872.
2. Blackley CH. Experimental researches on the causes and nature of Cattarrhus aestivus. London: Balliere, Trindall, & Cox; 1873.
3. Hurst DS, Gordon BR, Fornadley JA, et al. Safety of home-based and office allergy immunotherapy: a multicenter prospective study. Otolaryngol Head Neck Surg 1999;121:553-61.
4. Rinkel HJ. The management of clinical allergy: III inhalant allergy therapy. Arch Otolaryngol 1963;77:205-25.
5. Trevino RJ. Comparison of results of immunotherapy based on skin end-point titration, prick testing, and scratch testing. Otolaryngol Head Neck Surg 1994;111:550-2.
6. Krouse JH, Krouse HJ. Efficacy of immunotherapy based on skin end-point titration. Otolaryngol Head Neck Surg 2000;123:183-7.
7. Lee LK, Kniker WT, Campos T. Aggressive coseasonal immunotherapy in mountain cedar pollen allergy. Arch Otolaryngol 1982;108:787-94.
8. Council on Scientific Affairs (AMA). In vivo diagnostic testing and immunotherapy for allergy. JAMA;1987:1363-7.
9. American Academy of Allergy, Asthma, and Immunology. Position statements: Controversial techniques. 8. J Allergy Clin Immunol 1981;67:333-8.
10. Nelson HS, Oppenheimer J, Buchmeier A, et al. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol 1996;97:1193-201.
11. Menardo JL, Bosquet J, Michel FB. Comparison of three prick test methods with the intradermal test and with the RAST in the diagnosis of mite allergy. Ann Allergy 1982;48:235-9.
12. Schwindt DA, Hutcheson PS, Dykewicz MS. Positive intradermal tests with corresponding negative percutaneous tests fail to identify clinically relevant respiratory allergy assessed by nasal challenges. Paper presented at the annual meeting of the American Academy of Allergy Asthma, and Immunology, March 7-10, 1998. San Diego, Calif; March 1998.
13. Gungor A, Houser SM, Aquino BF, et al. Comparing skin endpoint titration to other forms of allergy testing. Paper presented at the spring meeting of the American Academy of Otolaryngic Allergy Foundation; Palm Desert, Calif; April 23, 1999.
14. Keenan JP. History of skin testing and evolution of skin endpoint titration. In: Mabry RL, editor. Skin endpoint titration. New York: Thieme; 1992. p. 12-6.
15. Shah SB, Emanuel I. Cost analysis of employing multi-test allergy screening to guide serial endpoint titration (SET) testing vs SET alone. Paper presented at the annual meeting of the American Academy of Otolaryngic Allergy Foundation; San Diego, Calif; September 18, 2002.
16. American Medical Association. Current procedural terminology 2003. Chicago: American Medical Association; 2003.
17. King WP. Efficacy of a screening radioallergosorbent test. Arch Otolaryngol 1982;108:781-6.
18. Tandy JR, Mabry RL, Mabry CS. Correlation of modified radioallergosorbent test scores and skin test results. Otolaryngol Head Neck Surg 1996;115:42-5.
19. Lehr AJ, Mabry RL, Mabry CS. The screening RAST: is it a valid concept? Otolaryngol Head Neck Surg 1997;117:54-5.
20. Anon JB. Otolaryngic allergy: the last half-century. Otolaryngol Clin North Am 1992;25:1-12.
21. Hansel FK. Coseasonal intracutaneous treatment of hay fever. J Allergy 1941;12:457-66.
22. Mabry RL. Blending skin endpoint titration and in vitro methods in clinical practice. Otolaryngol Clin North Am 1992;25:61-70.
23. Hurst DS, Gordon BR, Krouse JH. The importance of glycerin-containing negative control tests in allergy research studies that use intradermal skin tests. Otolaryngol Head Neck Surg 2002;127:177-81.
24. Kaliner MD. What actually happens in an allergy skin test. Immunol Allergy Practice 1987;9:74-9.
25. Rinkel HJ. The management of clinical allergy: II etiologic factors and skin titration. Arch Otolaryngol 1963;77:42-75.
26. Mabry RL. Whealing responses. In: Mabry RL, editor. Skin endpoint titration. 2nd ed. New York: Thieme Medical Publishers; 1994. p. 19-25.
27. Simons FE, Silver NA, Gu X, et al. Clinical pharmacology of H1-antihistamines in the skin. J Allergy Clin Immunol 2002;110:777-83.
28. Rao KS, Menon PK, Hilman BC, et al. Duration of the suppressive effect of tricyclic antidepressants on histamine-induced wheal-and-flare reactions in human skin. J Allergy Clin Immunol 1988;82:752-7.
29. Thomas RHM, Browne PD, Kirby JDT. The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal-and-flare reactions in human skin. J Allergy Clin Immunol 1985;76:864-9.
30. Des Roches A, Paradis L, Bougeard YH, et al. Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol 1996;98:522-7.
31. Simons FER, Johnston L, Gu X, et al. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. Ann Allergy Asthma Immunol 2001;86:44-50.
32. Nelson HS, Knoetzer J, Bucher B. Effect of distance between sites and region of the body on results of skin prick tests. J Allergy Clin Immunol 1996;97:596-601.
33. King HC, Mabry RL, Mabry CS. Allergy in ENT practice: a basic guide. New York: Thieme; 1998.
34. Krouse JH, Chadwick SJ, Gordon BR, Derebery MJ. Allergy and immunology: an otolaryngic approach. Philadelphia: Lippincott-Williams and Wilkins; 2002.
35. Smith TF. Allergy testing in clinical practice. Ann Allergy Asthma Immunol 1992;68:293-302.
36. Connell JT. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure and placebo challenge on the nasal membrane. J Allergy 1968;41:123-39.
37. Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988;81:1-5.
38. Nelson HS, Lahr J, Buchmeier A, et al. Evaluation of devices for skin prick testing. J Allergy Clin Immunol 1998;101:153-6.
39. Mahan C, Spector S, Siegel S, et al. Validity and reproducibility of multi-test skin test device. Ann Allergy 1993;71:25-8.
40. Murphree JT, Kniker WT. Correlation of immediate skin test responses to antigens introduced by multi-test and intracutaneous routes. Ann Allergy 1979;43:279-85.
41. Krouse JH. Modified quantitative testing (MQT) in clinical practice. Paper presented at the Annual Meeting of the American Academy of Otolaryngic Allergy; San Diego, Calif; September 18, 2002.
42. Krouse JH, Stachler RJ, Shah A. In vivo and in vitro screens for inhalant allergy. Otolaryngol Clin North Am. In press 2003.
43. American Medical Association Council on Scientific Affairs, Panel on Allergy. In vivo diagnostic testing and immunotherapy for allergy. JAMA 1987;258:1363-7.
44. Nelson HS, Knoetzer J, Bucher B. Effect of distance between sites and region of the body on results of skin prick tests. Journal Allergy Clin Immunol 1996;97:596-601.